Navigation Links
Gene May Boost Death Risk From Most Common Thyroid Cancer
Date:4/12/2013

FRIDAY, April 12 (HealthDay News) -- Researchers have pinpointed a genetic mutation that is strongly associated with an increased risk of death in people with thyroid cancer.

The investigators followed more than 1,800 patients after their initial treatment for papillary thyroid cancer, which accounts for 85 percent to 90 percent of all thyroid cancers.

After an average follow-up period of 33 months, 5 percent of those with the BRAF V600E mutation had died, compared with 1 percent of those without the mutation, according to the study in the April 10 issue of the Journal of the American Medical Association.

However, the link between this mutation and increased risk of death was not independent of tumor characteristics, the study authors noted in a journal news release.

This, and the fact that the overall death rate from papillary thyroid cancer is low, means that it is unclear how to use these findings to reduce death risk in patients with this type of cancer, said Dr. Mingzhao Xing, of the Johns Hopkins University School of Medicine, and colleagues.

The overall five-year survival rate for patients with papillary thyroid cancer is 95 percent to 97 percent. It's a challenge to distinguish patients who require aggressive treatment in order to reduce their risk of death from patients who do not, the researchers explained.

Even so, the authors of an accompanying editorial pointed out that the study provided important insight.

According to the editorialists, Dr. Anne Cappola and Dr. Susan Mandel of the University of Pennsylvania, "Although these findings do not support widespread BRAF V600E testing, they do support the need for additional study of how BRAF testing can be used to improve the already excellent prognosis of patients with papillary thyroid cancer."

While the study found an association between the gene mutation and thyroid cancer survival, it did not establish a cause-and-effect relationship.

More information

The American Cancer Society has more about thyroid cancer.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, April 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Vitamin D proven to boost energy -- from within the cells
2. New Electronic Earplugs Protect Ears and Boost Hearing
3. R.B.I. Vision Performance Supplement Boosts Athletic Ability Naturally
4. Bigorexics Want to Boost Their Masculinity
5. Facebook a Boost for Your Self-Worth?
6. Shorter Shifts for Medical Interns May Not Boost Patient Safety
7. News Coverage of Shootings May Boost Stigma of Mental Illness
8. #1 Natural Testosterone Booster Offers No Charge International Shipping of Their Highly Popular Mens All Natural Testosterone Supplement
9. Omega XL Reports New Independent Study: Omega-3s Can Boost Children’s IQ
10. Scientists ID Antibody That Might Boost Cancer Therapy
11. Oxblue Construction Cameras Help Two Universities Embarked on Major Building Projects Boost Stakeholder Confidence and Improve Project Management
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene May Boost Death Risk From Most Common Thyroid Cancer
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology: